Because a genotoxicity test is usually a qualitative method to identify the genotoxic hazard of chemical substances, the result is considered “positive” or “negative.” On the other hand, toxic chemical health risk assessments generally use a dose-response model, which includes a threshold below which no adverse health effects are detected. This allows us to establish an Acceptable Daily Intake (ADI). However, this becomes challenging when a chemical has been found to be carcinogenic and is then detected to have genotoxicity. Unlike other toxicities, genotoxicity is considered to have no threshold. Therefore, no ADI can be set because the theory states that the health risk does not become zero unless intake becomes zero. This is the specificity of risk assessments for genotoxic carcinogens. There is another method of risk assessment/management that is based on the following concept : “even if a substance has genotoxicity, it can be considered virtually safe as long as the exposure dose is sufficiently low to result in extremely low carcinogenicity with an acceptable level of risk”. This dose is called the virtually safe dose (VSD), and it adopts an acceptable risk level of 10
–5– 10
–6. Based on carcinogen databases, it is possible to conclude that the majority of chemicals would cause little virtual health hazard even if they are mutagenic carcinogens as long as their daily intake is below 1.5 μg/person. Such a comprehensive threshold is called the “threshold of toxicological concern (TTC)”. In this paper, I discuss the use of VSD and TTC for risk assessment and management of chemicals contained in foods (
e .g ., food additives, eluents from plastic containers, flavoring substances, residual pesticides). More than 40 years ago in Japan, 2-(2-furyl)-3-(5- nitro-2-furyl)-acrylamide (AF-2) was widely used as a food preservative for tofu, ham, sausage, fish paste etc. Later, discovery of the potent genotoxicity (mutagenicity) of AF-2 initiated extraordinarily heated discussions, and finally the use of AF-2 was banned in 1974. I re-assess the carcinogenic risk of AF-2 based on the current risk assessment method.
抄録全体を表示